CN107312778A - 一种癌症诊断试剂盒以及治疗用药物组合物 - Google Patents
一种癌症诊断试剂盒以及治疗用药物组合物 Download PDFInfo
- Publication number
- CN107312778A CN107312778A CN201710599756.6A CN201710599756A CN107312778A CN 107312778 A CN107312778 A CN 107312778A CN 201710599756 A CN201710599756 A CN 201710599756A CN 107312778 A CN107312778 A CN 107312778A
- Authority
- CN
- China
- Prior art keywords
- thyroid cancer
- mir
- cancer
- thyroid
- cell
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
- C12N15/113—Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing
- C12N15/1135—Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing against oncogenes or tumor suppressor genes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7088—Compounds having three or more nucleosides or nucleotides
- A61K31/7105—Natural ribonucleic acids, i.e. containing only riboses attached to adenine, guanine, cytosine or uracil and having 3'-5' phosphodiester links
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
- C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2310/00—Structure or type of the nucleic acid
- C12N2310/10—Type of nucleic acid
- C12N2310/14—Type of nucleic acid interfering N.A.
- C12N2310/141—MicroRNAs, miRNAs
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/158—Expression markers
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/178—Oligonucleotides characterized by their use miRNA, siRNA or ncRNA
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Genetics & Genomics (AREA)
- Organic Chemistry (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Molecular Biology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Biomedical Technology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biochemistry (AREA)
- Biotechnology (AREA)
- Analytical Chemistry (AREA)
- Microbiology (AREA)
- Biophysics (AREA)
- Physics & Mathematics (AREA)
- Pathology (AREA)
- Oncology (AREA)
- Immunology (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Hospice & Palliative Care (AREA)
- Plant Pathology (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Abstract
Description
Claims (5)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201710599756.6A CN107312778B (zh) | 2017-07-21 | 2017-07-21 | 一种癌症诊断试剂盒以及治疗用药物组合物 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201710599756.6A CN107312778B (zh) | 2017-07-21 | 2017-07-21 | 一种癌症诊断试剂盒以及治疗用药物组合物 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN107312778A true CN107312778A (zh) | 2017-11-03 |
CN107312778B CN107312778B (zh) | 2018-10-12 |
Family
ID=60178288
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201710599756.6A Active CN107312778B (zh) | 2017-07-21 | 2017-07-21 | 一种癌症诊断试剂盒以及治疗用药物组合物 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN107312778B (zh) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN112111578A (zh) * | 2020-09-04 | 2020-12-22 | 江南大学 | 全谷物膳食下脂质合成能力的miRNA标志物 |
CN113316721A (zh) * | 2019-01-11 | 2021-08-27 | 延世大学校产学协力团 | 用于靶向甲状腺髓样癌的组合物 |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN105497900A (zh) * | 2015-04-30 | 2016-04-20 | 苏州大学 | 一种抗未分化甲状腺癌耐药靶点及其应用 |
CN106687602A (zh) * | 2014-06-13 | 2017-05-17 | 维也纳自然资源与生命科学大学 | 用于诊断和治疗骨折和骨病的组合物及方法 |
-
2017
- 2017-07-21 CN CN201710599756.6A patent/CN107312778B/zh active Active
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN106687602A (zh) * | 2014-06-13 | 2017-05-17 | 维也纳自然资源与生命科学大学 | 用于诊断和治疗骨折和骨病的组合物及方法 |
CN105497900A (zh) * | 2015-04-30 | 2016-04-20 | 苏州大学 | 一种抗未分化甲状腺癌耐药靶点及其应用 |
Non-Patent Citations (2)
Title |
---|
CHENG ZHAN ET AL.: "Identification of reference miRNAs in human tumors by TCGA miRNA-seq data", 《BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS》 * |
Y.L. WANG ET AL.: "Effects of miR-27a upregulation on thyroid cancer cells migration, invasion, and angiogenesis", 《GENETICS AND MOLECULAR RESEARCH》 * |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN113316721A (zh) * | 2019-01-11 | 2021-08-27 | 延世大学校产学协力团 | 用于靶向甲状腺髓样癌的组合物 |
CN112111578A (zh) * | 2020-09-04 | 2020-12-22 | 江南大学 | 全谷物膳食下脂质合成能力的miRNA标志物 |
Also Published As
Publication number | Publication date |
---|---|
CN107312778B (zh) | 2018-10-12 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN103403181B (zh) | ncRNA及其用途 | |
CN105779618B (zh) | 一种舌鳞癌的新诊治靶标基因及其应用 | |
CN104818334B (zh) | 与肺腺癌转移相关的微小rna | |
WO2011121610A1 (en) | Micrornas (mirna) as biomarkers for detecting different grades of gliomas and pathways of glioma progression | |
CN109468382B (zh) | lncRNA在肺腺癌诊疗中的应用 | |
CN109182527B (zh) | 一种用于胶质瘤中预后评价及化疗效果预测的干扰素相关试剂盒 | |
CN107519193B (zh) | 食管鳞癌早期分子诊断标志物及其应用 | |
CN106967719B (zh) | 一种长链非编码rna作为前列腺癌分子标志物的应用 | |
CN114807372A (zh) | 人HHIPL2 mRNA在食管鳞状细胞癌靶向治疗和预后评估中的应用及试剂盒 | |
CN107312778B (zh) | 一种癌症诊断试剂盒以及治疗用药物组合物 | |
CN107586842A (zh) | 一种用于肾透明细胞癌诊治的生物标志物 | |
CN114150063A (zh) | 膀胱癌诊断用尿液miRNA标志物、诊断试剂及试剂盒 | |
CN112359118A (zh) | 长链非编码rna ac073352.1作为乳腺癌诊断标志物和治疗靶点的应用 | |
CN101988062A (zh) | 宫颈癌检测标记物及其检测方法、试剂盒和生物芯片 | |
CN107312851A (zh) | 心肌梗死生物标志物miR‑1283 | |
CN111979315A (zh) | 环状tp63作为肺鳞癌诊断或治疗靶点的应用 | |
CN105603117B (zh) | miR-3613用于区分肺鳞癌转移与非转移的miRNA标志物 | |
CN111808966B (zh) | miRNA在诊断乳腺癌患病风险的应用 | |
CN112029864B (zh) | 一种乳腺癌miRNA检测试剂盒及其应用 | |
CN109929844B (zh) | 一种胶质瘤预后标志物cpvl抑制剂及其应用 | |
CN106399485A (zh) | 一种在舌鳞癌癌旁组织中高表达的基因及其应用 | |
CN108165546A (zh) | 一种miRNA生物标志物、组合物及其用途 | |
CN105821131B (zh) | 骨肉瘤miRNA标记物 | |
CN104388541B (zh) | miR‑1914*和miR‑1915的用途 | |
Bustos et al. | Diagnostic miRNA Signatures in Paired Tumor, Plasma, and Urine Specimens From Renal Cell Carcinoma Patients |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
TA01 | Transfer of patent application right |
Effective date of registration: 20180828 Address after: 510320 the second level 203C unit of No. 1 production area, No. four helix Road, Haizhuqu District international biotic Island, Guangzhou, Guangdong. Applicant after: Guangzhou Da Yagao tung oil tree Laboratory of medical test Co.,Ltd. Address before: 450001 Basic Medical College of Zhengzhou University, 100 science Avenue, Zhengzhou, Henan Applicant before: Shen Yongzhi |
|
TA01 | Transfer of patent application right | ||
GR01 | Patent grant | ||
GR01 | Patent grant | ||
TR01 | Transfer of patent right |
Effective date of registration: 20210608 Address after: 510320 unit 214-52, 2nd floor, office area, No.1 helix 4th Road, Guangzhou International Biological Island, Haizhu District, Guangzhou City, Guangdong Province Patentee after: Difei medical technology (Guangzhou) Co.,Ltd. Address before: 510320 the second level 203C unit of No. 1 production area, No. four helix Road, Haizhuqu District international biotic Island, Guangzhou, Guangdong. Patentee before: Guangzhou Da Yagao tung oil tree Laboratory of medical test Co.,Ltd. |
|
TR01 | Transfer of patent right | ||
TR01 | Transfer of patent right |
Effective date of registration: 20230725 Address after: No. 128, Huakang Road, high tech Development Zone, Nanjing, Jiangsu 210032 Patentee after: Nanjing Shihe gene Biotechnology Co.,Ltd. Address before: 510320 unit 214-52, 2nd floor, office area, No.1 helix 4th Road, Guangzhou International Biological Island, Haizhu District, Guangzhou City, Guangdong Province Patentee before: Difei medical technology (Guangzhou) Co.,Ltd. |
|
TR01 | Transfer of patent right |